119 related articles for article (PubMed ID: 27022867)
1. Chitosan-modified lipid nanovesicles for efficient systemic delivery of l-asparaginase.
Wan S; He D; Yuan Y; Yan Z; Zhang X; Zhang J
Colloids Surf B Biointerfaces; 2016 Jul; 143():278-284. PubMed ID: 27022867
[TBL] [Abstract][Full Text] [Related]
2. Carboxymethyl-chitosan-tethered lipid vesicles: hybrid nanoblanket for oral delivery of paclitaxel.
Joshi N; Saha R; Shanmugam T; Balakrishnan B; More P; Banerjee R
Biomacromolecules; 2013 Jul; 14(7):2272-82. PubMed ID: 23721348
[TBL] [Abstract][Full Text] [Related]
3. The chemical modification of E. coli L-asparaginase by N,O-carboxymethyl chitosan.
Qian G; Zhou J; Ma J; Wang D; He B
Artif Cells Blood Substit Immobil Biotechnol; 1996 Nov; 24(6):567-77. PubMed ID: 8922226
[TBL] [Abstract][Full Text] [Related]
4. Immobilization of l-asparaginase on chitosan nanoparticles for the purpose of long-term application.
Baluchi A; Homaei A
Int J Biol Macromol; 2024 Feb; 257(Pt 1):128655. PubMed ID: 38065449
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial-Designed Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles for Encapsulation and Delivery of Lipid-Modified Platinum Derivatives in Wild-Type and Resistant Non-Small-Cell Lung Cancer Cells.
Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
Mol Pharm; 2015 Dec; 12(12):4466-77. PubMed ID: 26523837
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
[TBL] [Abstract][Full Text] [Related]
7. Modified-chitosan nanoparticles: Novel drug delivery systems improve oral bioavailability of doxorubicin.
Khdair A; Hamad I; Alkhatib H; Bustanji Y; Mohammad M; Tayem R; Aiedeh K
Eur J Pharm Sci; 2016 Oct; 93():38-44. PubMed ID: 27473308
[TBL] [Abstract][Full Text] [Related]
8. Local anesthetic lidocaine delivery system: chitosan and hyaluronic acid-modified layer-by-layer lipid nanoparticles.
Zhang L; Wang J; Chi H; Wang S
Drug Deliv; 2016 Nov; 23(9):3529-3537. PubMed ID: 27340888
[TBL] [Abstract][Full Text] [Related]
9. Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin.
Wan K; Sun L; Hu X; Yan Z; Zhang Y; Zhang X; Zhang J
Int J Pharm; 2016 May; 504(1-2):80-8. PubMed ID: 27034002
[TBL] [Abstract][Full Text] [Related]
10. Semi-permeable nanocapsules of konjac glucomannan-chitosan for enzyme immobilization.
Wang R; Xia B; Li BJ; Peng SL; Ding LS; Zhang S
Int J Pharm; 2008 Nov; 364(1):102-7. PubMed ID: 18725277
[TBL] [Abstract][Full Text] [Related]
11. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
Qiang F; Shin HJ; Lee BJ; Han HK
Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
[TBL] [Abstract][Full Text] [Related]
12. Catanionic Hybrid Lipid Nanovesicles for Improved Bioavailability and Efficacy of Chemotherapeutic Drugs.
Xie X; He D; Wu Y; Wang T; Zhong C; Zhang J
Methods Mol Biol; 2021; 2211():57-68. PubMed ID: 33336270
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
Luo Y; Teng Z; Li Y; Wang Q
Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662
[TBL] [Abstract][Full Text] [Related]
15. Structural evaluation of phospholipidic nanovesicles containing small amounts of chitosan.
Mertins O; Cardoso MB; Pohlmann AR; da Silveira NP
J Nanosci Nanotechnol; 2006 Aug; 6(8):2425-31. PubMed ID: 17037851
[TBL] [Abstract][Full Text] [Related]
16. Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.
Li L; Jiang G; Yu W; Liu D; Chen H; Liu Y; Tong Z; Kong X; Yao J
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):278-286. PubMed ID: 27770892
[TBL] [Abstract][Full Text] [Related]
17. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
18. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin.
Ridolfi DM; Marcato PD; Justo GZ; Cordi L; Machado D; Durán N
Colloids Surf B Biointerfaces; 2012 May; 93():36-40. PubMed ID: 22244299
[TBL] [Abstract][Full Text] [Related]
20. Temperature- and rigidity-mediated rapid transport of lipid nanovesicles in hydrogels.
Yu M; Song W; Tian F; Dai Z; Zhu Q; Ahmad E; Guo S; Zhu C; Zhong H; Yuan Y; Zhang T; Yi X; Shi X; Gan Y; Gao H
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5362-5369. PubMed ID: 30837316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
